ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD
2021 · Journal of Hepatology · 79 citations
https://doi.org/10.1016/j.jhep.2021.09.026
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
993
Citations
8
h-index
8
i10-index
Rebecca Pitts is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Advanced Proteomics Techniques and Applications & Alzheimer's disease research and treatments & Retinal Diseases and Treatments. The author has an h-index of 8, co-authored 11 publications.
ORCID: 0000-0003-4733-414Xhttps://doi.org/10.1016/j.jhep.2021.09.026
https://doi.org/10.1038/s43587-024-00693-1
Click to start Chat